Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.

NCT05431075 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT05431075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment: A Multicenter Randomized Clinical Trial of Different Tetracycline Doses and Frequencies.
Lead sponsor
Shandong University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2022
Completion date
February 1, 2024
Enrollment
406 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection